Results of treating uveal melanoma with proton beam radiation: 10-Year follow-up;Résultats du traitement du mélanome malin de l'uvée par faisceau de protons: 10 Ans de recul

Journal Francais d'Ophtalmologie

Volumn 28, Issue 8, 2005, Pages 833-839

  Hamrouni, Z ^a   Levy, C ^a   Lumbroso, L ^a   D'Hermies, F ^b   Frau, E ^c   Mazal, A ^d   Delacroix, S ^d   Nauraye, C ^d   Dendale, R ^a   Schlienger, P ^a   Desjardins, L ^a  

^a INSTITUT CURIE   (France)

^b HÔTEL DIEU   (France)

^c BICÊTRE HOSPITAL   (France)

^d Centre de Protonthérapie d'Orsay   (France)

Author keywords

Proton beam radiation; Uveal melanoma

Indexed keywords

COBALT 60;

A SCAN; ADOLESCENT; ADULT; AGED; ARTICLE; B SCAN; CATARACT; COBALT THERAPY; DEATH; ENUCLEATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; KERATITIS; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; NEUROPATHY; OPHTHALMOSCOPY; PROTON RADIATION; RECURRENCE RISK; RETINA DETACHMENT; RETINA MACULOPATHY; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; THORAX RADIOGRAPHY; TUMOR VOLUME; UVEA MELANOMA; VISUAL ACUITY; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE;

EID: 27644587034     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0181-5512(05)81001-0     Document Type: Article

References (25)

1. Gragoudas ES. Long-term results after proton irradiation of uveal melanomas. Graefes Arch Clin Exp Ophthalmolol, 1997;35:265-7.
2. Zografos L, Bercher L, Egger E, Chamot L, Gailloud C, Uffer S. Treatment of eye tumors by accelerated proton beams. 7-year experience. Klin Mbl Augenheilk, 1992;200:431-5.
3. Egger E, Zografos L, Schalenbourg A, Beati D, Böhringer T, Chamot L, Goitein G. Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiation Oncology Biol Phys, 2003;55:867-80.
4. Egger E, Zografos L, Munkel G, Böhringer T, Bercher L, Chamot L. Results of proton radiotherapy for uveal melanomas. Front Radiat Ther Oncol, 1997;30:111-22.
5. Lumbroso L, Levy C, Plancher C, Frau E. D'Hermies F. Résultats du traitement du mélanome malin de la choroide par faisceau de protons. J Fr Ophtalmol, 2002;25:209-7.
6. Gragoudas ES, Seddon JM, Egan KM, Glynn R, Goitein M, Munzenrider J, et al. Proton irradiation of uveal melanomas: the first 1000 patients. Amsterdam/New York: Kugler Publication; 1991.
7. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology, 1999;106:1579-87.
8. Li W, Gragoudas ES, Egan KM. Metastatic melanoma death rates by anatomic site after proton beam irradiation for uveal melanoma. Arch Ophthalmol, 2000;118:1066-9.
9. Li W, Gragoudas ES, Egan KM. Tumor basal area and metastatic death after proton beam irradiation for uveal melanoma. Arch Ophthalmol, 2003;121:68-72.
10. Gragoudas ES, Lane AM, Munzenrider J, Egan KM, Li W. Long-term risk of failure after proton therapy for choroidal/ciliary body melanoma. Trans Am Ophthalmol, 2002;100:43-50.
11. Gragoudas ES, Egan KM, Seddon JM, Walsh SM, Munzenrider J. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology, 1992;99:760-6.
12. Zografos L. Conservative treatment of uveal melanoma by accelerated proton beam. In: Tumors of the eye. Kugler Publications, Amesterdam/New York; 1991: p. 497-506.
13. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, et al. Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology, 1990;97:769-77.
14. Gragoudas ES, Seddon JM, Egan KM, Glynn RJ, Goitein M. Metastasis from uveal melanoma after proton beam irradiation. Ophthalmology, 1988;95:992-9.
15. Desjardins L, Lumbroso L, Levy C, Mazal A, Delacroix S, Rosenwald JC, et al. Traitement du mélanome choroïdien par disque d'iode 125 et faisceau de protons: indications respectives et comparaison des taux de récidive. J Fr Ophtalmol, 2003;26:269-76.
16. Char DH, Kroll S, Phillips TL. Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol, 1998;116:399-400.
17. Egan KM, Ryan LM, Gragoudas ES. Survival implications of enucleation after definitive radiotherapy for choroidal melanoma: an example of regression on time-depedent covariates. Arch Ophthalmol, 1998;165:370-5.
18. Seddon JM, Gragoudas ES, Polivogianis L, Hsieh CC, Egan KM, Goitein M, et al. Visual outcome after proton beam irradiation of choroidal melanoma. Ophthalmology, 1986;93:666-74.
19. Guyer DR, Mukai S, Egan K, Seddon JM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy aftr proton beam irradiation for choroidal melanoma. Ophthalmology, 1992;99:1278-85.
20. Gragoudas ES, Li W, Lane AM, Munzenrider J, Egan KM. Risks factors for radiation maculopathy and papillopathy after intraocular irradiation. Ophthalmology, 1999;106:1571-8.
21. Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Munzenrider J, Austin-Seymour M, et al. uveal melanomas near the optic disc or fovea. Visual results after proton beam irradiation. Ophthalmology, 1987;94:354-61.
22. Guyer DR, Mukai S, Egan KM, Seddon JM, Walsh SM, Gragoudas ES. Radiation maculopathy after proton beam irradiation for choroidal melanoma. Ophthalmology, 1992;99:1278-85.
23. Meyer A, Levy C, Blondel J, D'Hermies F, Frau E. Neuropathie optique après protonthérapie pour mélanome malin de la choroïde. J Fr Ophtalmol, 2000;23:543-53.
24. Park SS, Walsh SM, Gragoudas ES. Visual-field deficit associated with proton beam irradiation for parapapillary choroidal melanoma. Ophthalmology, 1996;103:110-6.
25. Brovkina AF, Kaplina AV, Zarubei GD. Post radiation secondary glaucoma and prevention measures. Vestn Oftalmol, 1991;107:16-20.